Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1347-2023Class II

CAPIOX FX25 Hollow Fiber Oxygenator, Catalog Numbers 3CX*FX25REC, 3CX*FX25RWC

Terumo Cardiovascular Systems Corporation / initiated 2023-03-01 / Open, Classified / root cause: manufacturing process

Terumo Cardiovascular Systems Corporation began a recall of CAPIOX FX25 Hollow Fiber Oxygenator, Catalog Numbers 3CX*FX25REC, 3CX*FX25RWC on . FDA classified it as Class II and gives the reason as "Some Capiox NX, RX and FX Oxygenators may contain an arterial thermistor component that is improperly bonded to the oxygenator port. This may result in a leak at the point where the arterial thermistor is improperly...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1347-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Terumo Cardiovascular Systems Corporation
Product
CAPIOX FX25 Hollow Fiber Oxygenator, Catalog Numbers 3CX*FX25REC, 3CX*FX25RWC
Product code
DTZ Oxygenator, Cardiopulmonary Bypass
Reason for recall
Some Capiox NX, RX and FX Oxygenators may contain an arterial thermistor component that is improperly bonded to the oxygenator port. This may result in a leak at the point where the arterial thermistor is improperly bonded to the oxygenator port.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
An URGENT MEDICAL DEVICE RECALL notification letter dated 3/1/23 was sent to customers. RECOMMENDED ACTIONS Terumo CVS advises users to remove all affected product from inventory and return unused product to Terumo CVS following the instructions provided in this notice. Terumo CVS will credit the user s accounts for returned, unused products. AFFECTED POPULATION The affected population is all patients on which an impacted Capiox NX, RX or FX Oxygenator is used. CUSTOMER INSTRUCTIONS - Review this Medical Device Recall notice and ensure that all users receive notice of this issue. Refer to the Customer Response Form to identify your product inventory that is subject to this action. Confirm receipt of this communication by completing and returning the attached Customer Response Form to the email address or fax number indicated on the form. Please return the Customer Response Form even if you no longer have the affected product in inventory. If the affected product has been distributed to another user or location, please forward a copy of the notice as needed. Terumo CVS will issue a Return Goods Authorization upon receipt of the Customer Response Form. Return all affected products to Terumo CVS. QUESTIONS? We encourage you to contact Terumo CVS with any questions or concerns: Terumo CVS Customer Service: 1.800.521.2818 Monday Friday, 8 a.m. 6 p.m. ET Terumo Recall Fax: 443-993-5738 or emailing [email protected] Terumo Recall Email: [email protected]
Quantity in commerce
4940 units
Distribution
US Nationwide. Belgium, Canada, Costa Rica, Thailand.
Product codes and lots
UDI-DI: (01)00699753450868; Lot Number AM03

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1347-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1345-2023Class IIOngoingVoluntary: Firm initiated
Z-1346-2023Class IIOngoingVoluntary: Firm initiated
Z-1347-2023Class IIOngoingVoluntary: Firm initiated